berlition has been researched along with Alzheimer Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrisano, V; Bartolini, M; Bolognesi, ML; Hrelia, P; Melchiorre, C; Minarini, A; Rosini, M; Tarozzi, A | 1 |
| Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Chierici, S; Demeunynck, M; Dubois-Dauphin, M; Garin, D; Laferla, FM; Mahon, AB; Oukhatar, F; Sallanon, MM; Try, AC | 1 |
| Andrisano, V; Bartolini, M; Bolognesi, ML; Hrelia, P; Matera, R; Melchiorre, C; Milelli, A; Rosini, M; Simoni, E; Tarozzi, A | 1 |
| Bautista-Aguilera, OM; Benchekroun, M; Buendía, I; Egea, J; Ismaili, L; Janockova, J; Jimeno, ML; Jun, D; León, R; Marco-Contelles, J; Michalska, P; Ouari, O; Refouvelet, B; Romero, A; Sepsova, V; Soukup, O | 1 |
| Abbas Bukhari, SN; Abdolahi, Z; Abdollahi, M; Ameri, A; Ayazgok, B; Baeeri, M; Emami, S; Forootanfar, H; Foroumadi, A; Ganjali, MR; Jafari, M; Jalili-Baleh, L; Khoobi, M; Küçükkılınç, TT; Nadri, H; Rahimifard, M | 1 |
1 review(s) available for berlition and Alzheimer Disease
| Article | Year |
|---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid | 2008 |
5 other study(ies) available for berlition and Alzheimer Disease
| Article | Year |
|---|---|
Rational approach to discover multipotent anti-Alzheimer drugs.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Butyrylcholinesterase; Cell Line; Cholinesterase Inhibitors; Humans; Neurons; Nootropic Agents; Reactive Oxygen Species; Structure-Activity Relationship; Tacrine; Thioctic Acid | 2005 |
Proflavine derivatives as fluorescent imaging agents of amyloid deposits.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Fluorescent Dyes; Mice; Mice, Transgenic; Microscopy, Fluorescence; Peptide Fragments; Plaque, Amyloid; Proflavine | 2011 |
Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Butyrylcholinesterase; Cell Line; Cholinesterase Inhibitors; Drug Discovery; Humans; Ligands; Peptide Fragments; Protein Multimerization; Protein Structure, Secondary; Thioctic Acid | 2011 |
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
Topics: Alzheimer Disease; Antioxidants; Cell Death; Cell Survival; Cholinesterase Inhibitors; Cholinesterases; Coumaric Acids; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Melatonin; Molecular Structure; NF-E2-Related Factor 2; Structure-Activity Relationship | 2016 |
Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cholinesterase Inhibitors; Cholinesterases; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Hydrogen Peroxide; Ligands; Molecular Docking Simulation; Molecular Structure; PC12 Cells; Protein Aggregates; Rats; Reactive Oxygen Species; Structure-Activity Relationship; Thioctic Acid | 2018 |